NR2E3 and hepatocellular carcinoma: Our study demonstrates that high NR2E3 levels are significantly associated with favorable clinical outcomes in HCC, even when other pro‐oncogenic factors such as Sp1, β‐catenin, and p300 exhibit high expression.